20 percent more patients were treated with proton therapy in 2019
An individual eye shield is made for each patient to protect the surrounding tissue from the proton beam. © HZB
Number of patients who received the proton therapy offered jointly by Charité and HZB. © HZB/J. Politt
For more than 20 years, Charité - Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have jointly offered the irradiation of eye tumors with protons. In 2019, more patients were treated in Berlin-Wannsee than ever before. 276 patients - 20 percent more than in the previous year - underwent proton therapy. The treatment is specialized in choroidal melanomas of the eye. The proton accelerator at HZB is the only treatment facility for this disease in Germany.
500 to 600 people in Germany are affected by a malignant choroidal melanoma every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be maintained to a satisfactory degree. "The energy of the proton beam can be adjusted in such a way that practically only the tumor receives the radiation. Since the protons have a straight trajectory, the lateral scattering is much less than with X-rays," explains Dr. Jens Heufelder, the senior medical physicist at Charité - Universitätsmedizin Berlin. The protons effectively destroy the tumor, while the surrounding healthy tissue is largely spared.
To cope with the increase in patients in 2019, treatment operations at the proton accelerator have been extended to 12 hours. Approximately 45 percent of the patients came from the Berlin-Brandenburg region, the other patients came from other German states and other European countries (approximately 8 percent). The youngest patient who received proton therapy at HZB in 2019 was 8 years old, the oldest patient 96 years old. The average age was 61 years.
Since 1998, more than 3,700 patients have been treated with protons from the HZB accelerator. "The success of proton therapy is based on the collaboration between ophthalmologists, medical physicists and accelerator experts. As a result, the therapy has been continuously improved for the benefit of patients over the past few years", explains Prof. Dr. Andrea Denker, head of proton therapy at HZB.
- BESSY II: High-resolution insights into individual biomolecules and catalystsVery small biological samples and even individual biomolecules can now be examined under near-physiological conditions with high confidence at the BESSY II infrared beamline with a newly validated and improved technique: The nanoscale infrared spectroscopy (s-SNOM) with ultra-thin silicon-based membranes. An international team demonstrated after an initial proof of concept, that high-resolution (a few tens of nanometres) nano-IR measurements reliably match expected far-field IR spectra in an aqueous environment. This methodological advance provides a solid foundation for studying biomaterials or observing catalytic processes in a liquid environment.
- New method shows how molecular switches are influenced by their neighborsResearchers at Friedrich Schiller University Jena and the Helmholtz Centre Berlin (HZB) have, for the first time, been able to directly observe how the environment surrounding a molecular switch influences its electronic structure. Molecular switches are molecules that can be switched between two states by external influences such as changes in temperature—similar to a switch with the positions »On« and »Off«. Such molecules are being investigated as potential building blocks for future data storage devices or sensor materials. Using magnetic-field-dependent terahertz spectroscopy, the researchers have now, for the first time, been able to distinguish whether neighbouring molecules in a material are in the same or different states. The results have been published in the journal »Angewandte Chemie International Edition«.
- 3D magnetic field experiment at BESSY II takes spintronics a step further(Fe0.63Ni0.3Pd0.07)3P or FNPP is a magnetic material that exhibits complex magnetic structures even at room temperature. This makes the material of interest for spintronics, a field that could enable data processing with significantly lower energy consumption. One potential application is novel magnetic memory devices. However, generating and modifying the desired structures in a controlled manner remains a challenge to date. A new study led by HZB has now taken a step forward in this regard. They demonstrated at the worldwide unique VEKMAG-Station at BESSY II, that a tiny external B-field in the plane of the magnetic patterns is sufficient to change them.